BNET Industries

Roche Holding AG

RHHBY is in the Pharma Industry

Market Cap:$93.2B
Last Fiscal Year Sales:$32.4B
  • Public
  • CH
Dow Jones Description

Roche's focus is health. Roche Holding Ltd. (OTC: RHHVF (ADR) Swiss) was founded in 1896 and is headquartered in Basel, Switzerland. The company operates in two segments, which are pharmaceuticals and diagnostics. Its drugs include Accutane, Herceptin, Invirase, Rituxan, Rocephin, Tamiflu, and Xenical, among others. It owns 60% of Genentech and 51% of Chugai Pharmaceutical. The company has annual revenue of about $27 billion and employs about 68,000 people. In 2005, it sold its consumer healthcare division to Bayer, allowing it to focus on core business.In July 2005 the company acquired GlycArt Biotechnology AG, a privately owned Swiss biotech company that provides technology for enhancing the efficacy of antibodies will further strengthen Roche's expertise in therapeutic antibody research and development.

Chief Executive OfficerSeverin Schwan
Number of Employees 80,080
Contact Information

Grenzacherstrasse 124

Basel CH-4070

www.roche.com

(41) 616881111

NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413

Recent Events

  • Covagen announces collaboration with Roche

    6/23/09 - Joint Venture / Alliance - View Story

  • Biogen says panel backs Genentech partnership

    6/16/09 - Merger / Acquisition - View Story

  • Raptor Pharmaceuticals announces licensing agreement with Roche Holding for NeuroTransTM

    6/10/09 - Joint Venture / Alliance - View Story

  • Roche teams with Pontifax on Israeli investments: The deal could be worth tens of millions...

    6/08/09 - Joint Venture / Alliance - View Story

  • Roche Downplays Avastin Failure, Defends Genentech Deal Value

    5/31/09 - Bond / Stock Rating - View Story

  • Tom Marsico Is Pound-the-Table Bullish

    5/28/09 - Merger / Acquisition - View Story

  • Drug firms eye deals to maintain growth

    5/10/09 - Merger / Acquisition - View Story

  • Roche teams with Spanish Lung Cancer Group to investigate Tarceva in lung cancer patients

    4/24/09 - Joint Venture / Alliance - View Story

  • (4/15) Roche's Pascal Soriot to lead Genentech

    4/18/09 - Merger / Acquisition - View Story

  • Roche says Genentech CEO will chair Genentech's new board

    4/15/09 - Mgmt. Change Leaving - CEO - View Story

  • SmarTrendR News Watch: Roche Says Genentech CEO Will Remain With The Company

    4/15/09 - Board Member - Entering - View Story

  • Pharma needs biotech for growth

    4/28/09 - Merger / Acquisition - View Story

  • UPDATE 3-Roche says Genentech's Levinson to stay on board

    4/14/09 - Mgmt. Change Entering - Vice President - View Story

News & Analysis

pharmaceutical company and roche holding ag - All News and Analysis

Decision Makers

Name (plus bio) Position
Severin Schwan Chief Executive Officer
William M. Burns CEO, Roche Pharma
Erich Hunziker CFO
Jonathan K.C. Knowles Managing Director, Global Pharmaceutical Research
Roche Rolf D Schl Managing Director, Partner
Rolf D Schl Managing Director, Partner
Andres Greuter Compliance Officer
Gottlieb A. Keller Secretary & Head, Corp Services, HR

Board of Directors

Name (plus bio) Position
Dr Roche Gottlieb Keller Chairman
Andre Hoffman Board of Directors
Andre Hoffmann Vice-Chairman of the Board
Andreas Oeri Board of Directors
Brouno Gehring Vice Chairman
Bruno Gehrig Vice Chairman
DeAnne S. Julius Board of Directors
F Hoffmann Vice chairman
Horst Teltschik Board of Directors
John Irving Bell Board of Directors
Lodewijk J.R. De Vink Board of Directors
Peter Brabeck-Letmathe Board of Directors
Roche Rolf H A nggi Vice-Chairman
Rolf Haenggi Board of Directors
Rolf Hanggi Board of Directors
Walter Frey Board of Directors
Organization Position Status
Roche Holding Ltd. Chief Executive Officer Current
University of Innsbruck Degree, Economics Former
University of Innsbruck Doctorate in Law Former
Organization Position Status
Roche Holding Ltd. CEO, Roche Pharma Current
Roche Products (Proprietary) Limited President Current
Chugai Pharmaceutical Co., Ltd. Board of Directors Current
Organization Position Status
Roche Holding Ltd. CFO Current
F. Hoffmann-La Roche Ltd. CFO Current
Chugai Pharmaceutical Co., Ltd. Board of Directors Current
Genentech, Inc. Board of Directors Current
Holcim Ltd. Board of Directors Current
Diethelm Keller Holding Ltd. Chief Executive Officer Former
Organization Position Status
Roche Holding Ltd. Managing Director, Global Pharmaceutical Research Current
Genentech, Inc. Head, Global Research Current
Genentech, Inc. Board of Directors Current
Chugai Pharmaceutical Co., Ltd. Board of Directors Current
University of East Anglia Honours Degree in Molecular Genetics Former
Organization Position Status
Roche Holding Ltd. Managing Director, Partner Current
Organization Position Status
Roche Holding Ltd. Managing Director, Partner Current
Organization Position Status
Roche Holding Ltd. Compliance Officer Current
Organization Position Status
Roche Diagnostics Corporation Secretary Current
Roche Holding Ltd. Secretary & Head, Corp Services, HR Current
Roche Holding Ltd. Board of Directors Current
Roche Diagnostics Corporation Secretary Former
Organization Position Status
Roche Holding Ltd. Chairman Current
Organization Position Status
Roche Holding Ltd. Board of Directors Current
Organization Position Status
Living Planet Management Company Chairman Current
Roche Holding Ltd. Vice-Chairman of the Board Current
Roche Holding Ltd. Member Current
Nestle Uk Ltd Brand Manager Former
INSEAD Masters of Business Administration Former
Organization Position Status
Roche Holding Ltd. Board of Directors Current
University of Basel Medical Studies Former
Organization Position Status
Roche Holding Ltd. Vice Chairman Current
Organization Position Status
Roche Holding Ltd. Vice Chairman Current
Roche Holding Ltd. Board of Directors Current
University of Bern Doctorate in economics (Dr Former
Organization Position Status
The Royal Institute of International Affairs Chairman Current
Roche Holding Ltd. Board of Directors Current
BP plc Board of Directors Current
University of California Ph.D In Economics Former
Iowa State University Ph.D Former
Iowa State University Bsc Former
Organization Position Status
Roche Holding Ltd. Vice chairman Current
Roche Holding Ltd. Chief Executive Officer Former
Diageo plc Board member Former
Organization Position Status
Roche Holding Ltd. Board of Directors Current
Organization Position Status
Roche Holding Ltd. Board of Directors Current
Organization Position Status
Roche Holding Ltd. Board of Directors Current

Peter Brabeck-Letmathe has been a member of the Board since 1997 and served as Vice-Chairman from 2000 to 2005 and since 2008. Since 2008 he has also served on the Chairman's and Governance Committee and the Compensation Committee. On both of these committees he has already served in the past, namely from 2003 to 2005 and 2000 to 2005, respectively. His term as a member of the Board expires at the AGM in 2011. The Board has determined him to be independent under the Group’s independence standards. Peter Brabeck-Letmathe studied Economics at the University of World Trade in Vienna. After graduation in 1968, he joined Nestlé’s sales operations in Austria. His career at Nestlé includes a variety of assignments in several European countries as well as in Latin America. Since 1987, he has been based at Nestlé’s headquarters in Vevey. Since 1997, Mr. Brabeck-Letmathe has served as the Chief Executive Officer of Nestlé and as a member of Nestlé’s Board of Directors. In 2005, Mr. Brabeck-Letmathe was appointed Chairman of the Board of Directors of Nestlé. As of April 10, 2008 he has retired from his function as Chief Executive Officer of Nestlé. Mr. Brabeck is a member of the Boards of Directors of L’Oréal SA, Paris (since 1997) and Roche Holding SA, Basel (since 2000). He is also a member of the Foundation Board of the World Economic Forum and a member of the European Round Table of Industrialists.

Organization Position Status
Credit Suisse Group Vice Chairman Current
Winterthur Schweizerische Versicherungs Gesellschaft Vice Chairman Current
Credit Suisse Group Board of Directors Current
Nestle S.A. Board of Directors Current
L'Oreal S.A. Board of Directors Current
Roche Holding Ltd. Board of Directors Current
World Economic Forum Member, Foundation Board Current
Nestle S.A. Chief Executive Officer Former
Organization Position Status
Roche Holding Ltd. Vice-Chairman Current
Zurich Insurance Company Deputy Chief Executive Officer Former
Zurich Insurance Member Former
Zurich Insurance Company Member Former
Nestle S.A. Vice-Chairman Former
Organization Position Status
Roche Holding Ltd. Board of Directors Current
Roche Holding Ltd. Vice Chairman Current
Organization Position Status
Roche Holding Ltd. Board of Directors Current
Nestle S.A. Second Vice Chairman Current
Nestle S.A. Second Vice Chairman Current
Zurich Insurance Company Deputy Chief Executive Officer Former
Zurich Insurance Company Member Former
Zurich Insurance Member Former
Nestle S.A. Vice-Chairman Former
Organization Position Status
Roche Holding Ltd. Board of Directors Current

Executive News

  • BP Selects New Chairman

    Rigzone - 6/26/09 - View Story

  • BP: BP Selects New Chairman to Succeed Peter Sutherland

    TradingMarkets - 6/25/09 - View Story

  • KineMed to Collaborate with Bristol-Myers Squibb

    TradingMarkets - 6/01/09 - View Story

  • Cancer Drugs: Herceptin News and More

    BusinessWeek - 6/01/09 - View Story

  • Cancer Drugs: News from ASCO

    BusinessWeek - 5/31/09 - View Story